What is Perry Kamel, MD?
Led by Dr. Perry Kamel, a board-certified gastroenterologist with over 25 years of clinical expertise, the practice serves as a critical hub for patients managing complex gastrointestinal conditions. The firm specializes in the diagnosis and treatment of Inflammatory Bowel Disease (IBD), Irritable Bowel Syndrome (IBS), and Gastroesophageal Reflux Disease (GERD). Beyond chronic disease management, the practice maintains a robust preventative care portfolio, offering essential services such as colon cancer screenings, colonoscopies, and endoscopies. By integrating high-level clinical proficiency with a patient-centric model, the practice has solidified its position as a leader in the Chicago medical landscape, effectively bridging the gap between academic-level care and private practice accessibility.
How much funding has Perry Kamel, MD raised?
Perry Kamel, MD has raised a total of $37K across 1 funding round:
Debt
$37K
Debt (2021): $37K with participation from PPP
Key Investors in Perry Kamel, MD
PPP
Public-Private Partnership
What's next for Perry Kamel, MD?
With the infusion of this recent capital, Perry Kamel, MD is well-positioned to scale its service delivery and enhance its technological infrastructure. The strategic focus for the coming fiscal periods will likely involve optimizing patient throughput and expanding the scope of diagnostic capabilities to meet the rising prevalence of digestive health issues. As the practice navigates this growth phase, the investment will facilitate the acquisition of advanced medical equipment and the potential expansion of clinical staff, ensuring that the organization remains at the forefront of gastroenterological care. This financial milestone serves as a testament to the practice's operational stability and its long-term commitment to improving patient outcomes through specialized, evidence-based medical interventions.
See full Perry Kamel, MD company page
